申请人:Ionis Pharmaceuticals, Inc.
公开号:US20200048638A1
公开(公告)日:2020-02-13
The present embodiments provide methods, compounds, and compositions for treating, preventing, or ameliorating a disease associated with dysregulation of the complement alternative pathway by administering a Complement Factor B (CFB) specific inhibitor to a subject.